Trial intelligence / Profile preview

5-Minute Amifostine Infusion in Chemotherapy

NCT00003252Phase 4Completed

Sponsor
Rush North Shore Medical Center
Start
Dec 1997
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amifostine in chemotherapy-induced toxicity, sponsored by Rush North Shore Medical Center. Started Dec 1997; status: completed.

02

Drugs

amifostine
03

Conditions

chemotherapy-induced toxicity

Beyond the preview

Go deeper on NCT00003252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call